Ad-IFN-beta gene therapy (University of Pennsylvania)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAd-IFN-beta gene therapy (University of Pennsylvania)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInterferon beta stimulants
TargetsInterferon beta
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsMesothelioma

Other Information

ATC CodeN/A
Related LinksN/A